Image-Guided Robotic Stereotactic Radiation Therapy with Fiducial-Free Tumor Tracking for Lung Cancer

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Bibault, Jean Emmanuel ^a   Prevost, Bernard ^a   Dansin, Eric ^b   Mirabel, Xavier ^a   Lacornerie, Thomas ^a   Lartigau, Eric ^a  

^a UNIV LILLE   (France)

^b Oscar Lambret Comprehensive Cancer Center   (France)

Author keywords

CyberKnife; Efficacy; Hypofractionated; Lung Cancer; Robotic Stereotactic Body Radiation Therapy; Toxicity; Xsight Lung

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; FEMALE; FIDUCIAL MARKER; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE GUIDED ROBOTIC STEREOTACTIC RADIATION THERAPY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SELECTION; PNEUMOTHORAX; POSITRON EMISSION TOMOGRAPHY; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; ROBOTICS; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; ROBOTICS; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84862529723     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-102     Document Type: Article

References (19)

1. Whyte RI, Crownover R, Murphy MJ, et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thor Surg. 2003, 75:1097.
2. Geraghty PR, Kee ST, McFarlane G, et al. CT-guided Transthoracic Needle Aspiration Biopsy of Pulmonary Nodules: Needle Size and Pneumothorax Rate. Radiology. 2003, 229:475-481. 10.1148/radiol.2291020499, 14595149.
3. Saji H, Nakamura H, Tsuchida T, et al. The Incidence and the Risk of Pneumothorax and Chest Tube Placement After Percutaneous CT-Guided Lung Biopsy. Chest. 2002, 121:1521-1526. 10.1378/chest.121.5.1521, 12006438.
4. Reichner CA, Collins BT, Gagnon GJ, et al. The placement of gold fiducials for CyberKnife stereotactic radiosurgery using a modified transbronchial needle aspiration technique. J Bronchol. 2005, 12:193.
5. Yeow KM, Su I, et al. Risk Factors of Pneumothorax and Bleeding. Chest 2004, 126:748. 10.1378/chest.126.3.748, 15364752.
6. Fu D, Kahn R, Wang B, et al. Fiducial-free Lung Tumor Tracking for CyberKnife Radiosurgery. Int J Radiat Oncol Biol Phys. 2008, 72:S608-S609.
7. Fu D, Kuduvalli G. Enhancing skeletal features in digitally reconstructed radiographs 2006, Image Processing.Vol 6144, San Diego, CA, USA.
8. Sayeh S, Wang J, Main W, Kilby W, Maurer C. Respiratory Motion Tracking for Robotic Radiosurgery. Dans: Treating Tumors that Move with Respiration. Springer. Urschel, Harold C 2007, 15:15-29.
9. Schweikard A, Glosser G, Bodduluri M, Murphy MJ, Adler JR. Robotic motion compensation for respiratory movement during radiosurgery. Comput Aided Surg. 2000, 5:263-277. 10.3109/10929080009148894, 11029159.
10. Schweikard A, Shiomi H, Adler J. Respiration tracking in radiosurgery. Med Phys. 2004, 31:2738. 10.1118/1.1774132, 15543778.
11. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 2000, 92:205-216. 10.1093/jnci/92.3.205, 10655437.
12. Nuyttens JJ, Prévost J-B, Praag J, et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results. Acta Oncol. 2006, 45:961-965. 10.1080/02841860600902205, 16982564.
13. Collins B, Erickson K, Reichner C, et al. Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol. 2007, 2:39. 10.1186/1748-717X-2-39, 2174503, 17953752.
14. Castelli J, Thariat J, Benezery K, et al. Analyse de la toxicité précoce des traitements par Cyberknife® des cancers pulmonaires et résultats préliminaires. Cancer Radiother. 2008, 12:793-799. 10.1016/j.canrad.2008.06.002, 18706844.
15. van Zyp NC VDV, Prévost JB, Hoogeman MS, et al. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: Clinical outcome. Radiother Oncol 2009, 91:296-300. 10.1016/j.radonc.2009.02.011, 19297048.
16. Herder GJ, Van Tinteren H, Colding RP, et al. Clinical prediction model to characterize pulmonary nodules: Validation and added value of 18 F-fluorodeoxyglucose positron emission tomography. Chest. 2005, 128:2490-2496. 10.1378/chest.128.4.2490, 16236914.
17. Aoki T, Nagata Y, Negoro Y, et al. Evaluation of Lung Injury after Three-dimensional Conformal Stereotactic Radiation Therapy for Solitary Lung Tumors: CT Appearance. Radiology. 2004, 230:101-108. 10.1148/radiol.2301021226, 14645881.
18. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys. 2005, 63:5-24. 10.1016/j.ijrobp.2005.03.047, 15963660.
19. Takeda T, Takeda A, Kunieda E, et al. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT. Am J Roentgenol. 2004, 182:1123.